We are live on ! Find out more
EHI

Eagle Health Investments Portfolio holdings

AUM $603M
1-Year Est. Return 111.06%
This Fund
S&P 500
This Quarter Est. Return
+1.25%
1 Year Est. Return
+111.06%
3 Year Est. Return
+240.87%
5 Year Est. Return
+290.92%
10 Year Est. Return
–
AUM
$255M
AUM Growth
+$98.4M
Cap. Flow
+$101M
Cap. Flow %
39.81%
Top 10 Hldgs %
65.11%
Holding
28
New
4
Increased
17
Reduced
2
Closed
3

Top Buys

Rank Stock Value
1
AGIO icon
Agios Pharmaceuticals
AGIO
+$14.1M
2
NTRA icon
Natera
NTRA
+$9.84M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$8M
4
INSP icon
Inspire Medical Systems
INSP
+$7.96M
5
ARGX icon
argenx
ARGX
+$7.28M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$6.71M
2
ILMN icon
Illumina
ILMN
+$5.81M
3
BFLY icon
Butterfly Network
BFLY
+$2.26M
4
TMO icon
Thermo Fisher Scientific
TMO
+$1.86M
5
GH icon
Guardant Health
GH
+$635K

Sector Composition

Rank Sector Weight
1 Healthcare 95.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IQV icon
1
IQVIA
IQV
$40B
$19.3M 7.59%
100,177
+27,800
+38% +$5.22M
VRTX icon
2
Vertex Pharmaceuticals
VRTX
$132B
$19M 7.46%
88,444
+36,444
+70% +$8M
HUM icon
3
Humana
HUM
$46.2B
$18.8M 7.39%
44,921
+13,759
+44% +$5.49M
AGIO icon
4
Agios Pharmaceuticals
AGIO
$1.94B
$18.3M 7.19%
354,650
+284,950
+409% +$14.1M
AZN icon
5
AstraZeneca
AZN
$251B
$17.7M 6.96%
178,395
+63,345
+55% +$6.37M
NTRA icon
6
Natera
NTRA
$46.4B
$17.1M 6.71%
168,394
+89,794
+114% +$9.84M
UTHR icon
7
United Therapeutics
UTHR
$22.7B
$15.6M 6.11%
93,100
+23,100
+33% +$3.85M
ALNY icon
8
Alnylam Pharmaceuticals
ALNY
$29B
$15.3M 6%
108,179
+22,386
+26% +$3.37M
BPMC
9
DELISTED
Blueprint Medicines
BPMC
$12.9M 5.08%
133,163
+71,103
+115% +$7.1M
ARGX icon
10
argenx
ARGX
$54.2B
$11.7M 4.61%
42,632
+23,045
+118% +$7.28M
AXNX
11
DELISTED
Axonics, Inc. Common Stock
AXNX
$11.7M 4.58%
194,965
+12,125
+7% +$659K
TMO icon
12
Thermo Fisher Scientific
TMO
$221B
$9.56M 3.75%
20,951
-3,900
-16% -$1.86M
UTHR icon
13
PUT
United Therapeutics
UTHR
$22.7B
$8.36M 3.28%
+50,000
New +$8.34M
ADPT icon
14
Adaptive Biotechnologies
ADPT
$4.09B
$8.14M 3.2%
202,220
+118,685
+142% +$6.42M
INSP icon
15
Inspire Medical Systems
INSP
$1.73B
$7.75M 3.04%
+37,453
New +$7.96M
CANO
16
DELISTED
Cano Health, Inc.
CANO
$6.57M 2.58%
4,961
+3,078
+163% +$4.36M
MRTX
17
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$6.24M 2.45%
+36,400
New +$7.21M
OM icon
18
Outset Medical
OM
$94M
$5.29M 2.08%
6,487
+1,687
+35% +$1.3M
DXCM icon
19
DexCom
DXCM
$33.2B
$4.96M 1.95%
55,200
– –
GH icon
20
Guardant Health
GH
$22.8B
$4.31M 1.69%
28,260
-4,200
-13% -$635K
SEER icon
21
Seer Inc
SEER
$121M
$4.18M 1.64%
83,500
+63,500
+318% +$3.71M
CMAX
22
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$4.12M 1.62%
11,336
+10,436
+1,160% +$4.41M
DRNA
23
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$4.12M 1.62%
161,125
+92,125
+134% +$2.35M
FDMT icon
24
4D Molecular Therapeutics
FDMT
$572M
$2.17M 0.85%
50,000
– –
OLK
25
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
$1.44M 0.57%
+40,000
New +$1.35M
1
2

Similar funds

PIFP
Partners in Financial Planning Salem, Virginia $603M AUM 12.72% 1-Year Est. Return
IECM
Intrinsic Edge Capital Management Chicago, Illinois $603M AUM 66.97% 1-Year Est. Return
ERWM
Elk River Wealth Management Denver, Colorado $602M AUM 22.77% 1-Year Est. Return
CIG
Capricorn Investment Group Palo Alto, California $602M AUM 165.22% 1-Year Est. Return
JHCP
Jackson Hole Capital Partners Tulsa, Oklahoma $605M AUM 22.77% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
OCAM
Onex Canada Asset Management Toronto, Ontario, Canada $601M AUM 15.16% 1-Year Est. Return

Eagle Health Investments's Q1 2021 Portfolio in Review

As of Q1 2021, Eagle Health Investments held 28 positions worth $255M, up 63% from $156M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Eagle Health Investments deployed $101M of net new capital in Q1 2021, opening 4 new positions and adding to 17 existing holdings. Its largest new stake was Inspire Medical Systems: 37,453 shares worth $7.75M.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, down from 99% a quarter earlier.

On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $1.86M trimmed.

  • Eagle Health Investments's largest Q1 2021 buy was Inspire Medical Systems: 37,453 shares worth $7.75M.
  • Eagle Health Investments added most to Agios Pharmaceuticals in Q1 2021, an estimated $14.1M increase.
  • Eagle Health Investments's biggest Q1 2021 reduction was Thermo Fisher Scientific, cutting an estimated $1.86M.
  • Eagle Health Investments fully exited Alexion Pharmaceuticals in Q1 2021, selling an estimated $6.71M.
  • Eagle Health Investments's ten largest holdings make up 65% of its $255M portfolio in Q1 2021.
  • Eagle Health Investments opened 4 new positions and closed 3 in Q1 2021.
  • Eagle Health Investments's portfolio value rose 63% quarter-over-quarter to $255M.

Based on Eagle Health Investments's 13F filing for Q1 2021, filed 23 Apr 2021.